Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

Post time 2024-4-23 05:54:12

journal：JAMA Dermatology

Authors：Sophie Glatt; Gregor B. E. Jemec; Seth Forman; Christopher Sayed; George Schmieder; Jamie Weisman; Robert Rolleri; Seth Seegobin; Dominique Baeten; Lucian Ionescu; Christos C. Zouboulis; Stevan Shaw

Published date：2021-11-1

DOI：10.1001/jamadermatol.2021.2905

PDF link：https://jamanetwork.com/journals ... 636039123.07222.pdf

Article link：http://dx.doi.org/10.1001/jamadermatol.2021.2905

Article Source：American Medical Association (AMA)。

Remark：

Post time 2024-4-23 05:54:13

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa Copy